571 related articles for article (PubMed ID: 30814351)
1. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
[TBL] [Abstract][Full Text] [Related]
2. Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Kikuchi M; Miyashita A; Hara N; Kasuga K; Saito Y; Murayama S; Kakita A; Akatsu H; Ozaki K; Niida S; Kuwano R; Iwatsubo T; Nakaya A; Ikeuchi T; ;
Alzheimers Res Ther; 2024 Feb; 16(1):45. PubMed ID: 38414085
[TBL] [Abstract][Full Text] [Related]
3. Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
Fan L; Borenstein AR; Wang S; Nho K; Zhu X; Wen W; Huang X; Mortimer JA; Shrubsole MJ; Dai Q;
EBioMedicine; 2023 Nov; 97():104818. PubMed ID: 37793213
[TBL] [Abstract][Full Text] [Related]
4. Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer's Disease.
Ma LZ; Wang ZX; Wang ZT; Hou XH; Shen XN; Ou YN; Dong Q; Tan L; Yu JT
Neurotox Res; 2021 Jun; 39(3):609-617. PubMed ID: 33216282
[TBL] [Abstract][Full Text] [Related]
5. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
[TBL] [Abstract][Full Text] [Related]
6. Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Martinez-Torteya A; Gomez-Rueda H; Trevino V; Farber J; Tamez-Pena J; For The Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2018; 15(8):751-763. PubMed ID: 29422002
[TBL] [Abstract][Full Text] [Related]
7. Harnessing forgetfulness: can episodic-memory tests predict early Alzheimer's disease?
Warren SL; Moustafa AA; Alashwal H;
Exp Brain Res; 2021 Sep; 239(9):2925-2937. PubMed ID: 34313791
[TBL] [Abstract][Full Text] [Related]
8. Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
Iwatsubo T; Iwata A; Suzuki K; Ihara R; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; ; Sun CK; Beckett LA; Petersen RC; Weiner MW; Aisen PS; Donohue MC;
Alzheimers Dement; 2018 Aug; 14(8):1077-1087. PubMed ID: 29753531
[TBL] [Abstract][Full Text] [Related]
9. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
[TBL] [Abstract][Full Text] [Related]
10. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
11. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
[TBL] [Abstract][Full Text] [Related]
12. Body Mass Index and Polygenic Risk for Alzheimer's Disease Predict Conversion to Alzheimer's Disease.
Moody JN; Valerio KE; Hasselbach AN; Prieto S; Logue MW; Hayes SM; Hayes JP;
J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):1415-1422. PubMed ID: 33880516
[TBL] [Abstract][Full Text] [Related]
13. Structural, static, and dynamic functional MRI predictors for conversion from mild cognitive impairment to Alzheimer's disease: Inter-cohort validation of Shanghai Memory Study and ADNI.
Chen Z; Chen K; Li Y; Geng D; Li X; Liang X; Lu H; Ding S; Xiao Z; Ma X; Zheng L; Ding D; Zhao Q; Yang L;
Hum Brain Mapp; 2024 Jan; 45(1):e26529. PubMed ID: 37991144
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
Kiselica AM; Benge JF;
Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
[TBL] [Abstract][Full Text] [Related]
15. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
17. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
[TBL] [Abstract][Full Text] [Related]
18. [Current topics about mild cognitive impairment (MCI)].
Yamamoto Y
Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
20. Predicting Alzheimer's conversion in mild cognitive impairment patients using longitudinal neuroimaging and clinical markers.
Platero C; Tobar MC;
Brain Imaging Behav; 2021 Aug; 15(4):1728-1738. PubMed ID: 33169305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
